Leveraging Human Genetics To Advance Cell Therapies For Treatment Of Blood Cancers […]
Publication Programs: Platform
Rocky Conference – 2022 – Poster Presentation 71
A machine learning approach incorporating germline information improves genotyping of CRISPR-Cas9 gene editing events at single cell resolution […]
Read More… from Rocky Conference – 2022 – Poster Presentation 71
ASH – 2022 – Poster Presentation 4587
Efficient Multiplex Gene Editing of CD33 and CLL-1 in Human Hematopoietic Stem Cells Enables the Potential of Next-Generation Transplants for AML Treatment […]
SITC – 2022 – Poster Presentation P334
Functional Validation of Single Domain Antibody-Derived CD33 Specific CAR-T Cells for the Treatment of Acute Myeloid Leukemia […]
ESGCT – 2022 – Poster Presentation P432
Multiplex deletion of myeloid antigens by base editing in human hematopoietic stem and progenitor cells (HSPCs) enables potential for next generation transplant for acute myeloid leukemia (AML) treatment […]
ESGCT – 2022 – Poster Presentation P150
Efficient knockout of both CD33 and CLL-1 by multiplex genome editing of human hematopoietic stem cells enhances the potential of next- generation transplants for acute myeloid leukemia (AML) treatment […]
Bioprocess International – 2022 – Poster Presentation CT11
Automated Closed Cell Processing System De-Risks Gene-Edited CD34+ Hematopoietic Stem Cell Manufacturing […]
Read More… from Bioprocess International – 2022 – Poster Presentation CT11
ISMB – 2022 – Poster Presentation 859
TransACT enhances detection and characterization of translocation events from high-throughput sequencing data at base-pair resolution for gene editing products […]
EHA – 2022 – Poster Presentation 1429
Multiplex Deletion of Myeloid Antigens CD33 and CLL-1 by CRISPR/Cas9 in Human Hematopoietic Stem Cells Highlights the Potential of Next-Generation Transplantation for AML Treatment […]